Saturday, August 15, 2026
Facts you can rely on·101 entities·4,805 sourced facts
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 5, 2026

Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

View original at globenewswire.com
Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider Austin, United States, Feb…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The market is challenged by high development costs, complex manufacturing processes, and strict regulatory requirements

    80% confidence
  • Adult vaccines held the largest share of 39.61% in 2025

    80% confidence
  • HPV vaccines are anticipated to record the fastest CAGR of 7.34% through 2026–2033

    80% confidence
  • Research & Academic Institutes are forecasted to register the fastest CAGR of 7.21% during 2026–2033

    80% confidence
  • Intramuscular vaccines accounted for the highest market share of 46.32% in 2025

    80% confidence
  • The U.S. Human Vaccines Market is expected to grow from USD 11.72 billion in 2025 to USD 15.17 billion by 2033, registering a CAGR of 3.30% during the forecast period

    80% confidence
  • Hospital Pharmacy held the largest share of 45.87% in 2025

    80% confidence
  • Inactivated vaccines held the largest market share of 28.74% in 2025

    80% confidence
  • Intradermal delivery is projected to expand at the fastest CAGR of 6.45% during the forecast period

    80% confidence
  • The Human Vaccines Market is driven by the rising awareness of preventive healthcare, expansion of national immunization programs, and rising cases of infectious and chronic diseases

    80% confidence
  • Online Pharmacy is expected to grow at the fastest CAGR of 6.78% during 2026–2033

    80% confidence
  • mRNA vaccines are expected to grow at the fastest CAGR of 7.12% during 2026–2033

    80% confidence
  • The Asia Pacific Human Vaccines Market is the fastest-growing globally, projected to register a CAGR of 5.89% during 2026–2033

    80% confidence
  • Geriatric vaccines are expected to grow at the fastest CAGR of 6.98% during 2026–2033

    80% confidence
  • Government vaccination programs are an essential factor in the development of the market

    80% confidence
  • COVID-19 vaccines dominated with a 31.25% share in 2025

    80% confidence
  • North America dominated the Human Vaccines Market, accounting for a 34.56% market share in 2025

    80% confidence
  • The Human Vaccines Market size was valued at USD 44.26 billion in 2025 and is expected to reach USD 62.45 billion by 2033, growing at a CAGR of 4.43% during the forecast period of 2026-2033

    80% confidence
  • Hospitals accounted for the largest share of 53.12% in 2025

    80% confidence